FIELD: medicine, pharmacy. SUBSTANCE: invention relates to a pharmaceutical composition showing antitumor activity and inducing interferon synthesis. The composition has lipid component, for example, "Lipofectin" (trade mark), 3-O-(4- -dimethylaminobutano)-1,2-O-dioleoylglycerol, 3-O-(2-dimethyl- -aminoethyl)-carbamoyl-1,2-O-dioleoylglycerol, 3-O-(2-diethyl- -aminoethyl)-carbamoyl-1,2-O-dioleoylglycerol or 2-O-(2- -diethylaminoethyl)-carbamoyl-1,3-O-dioleoylglycerol and copolymer of adenylic and uridylic acids. The composition shows the combined use of lipid system and copolymers of single-chain nucleic acids. EFFECT: enhanced activity of the composition. 5 cl, 2 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLYCEROL DERIVATIVES, AN AGENT FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2123492C1 |
| CONDENSED PYRIDAZINE DERIVATIVES AND DRUGS HAVING THE COMPOUNDS AS ACTIVE INGREDIENTS | 2003 |
|
RU2292337C2 |
| ACTIVATOR OF CANCER CELL INTRACELLULAR NUCLEASE | 1998 |
|
RU2183460C2 |
| DERIVATIVES OF PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASE | 1996 |
|
RU2170734C2 |
| NOVEL BETA-LACTAMASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2693898C2 |
| NITROGEN CONTAINING HETEROCYCLIC DERIVATIVE SHOWING TYPE I 11β -HYDROXYSTEROIDDEHYDROGENASE INHIBITORY ACTIVITY | 2008 |
|
RU2455285C2 |
| NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
| QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2544530C2 |
| NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS AND PHARMACEUTICAL AGENT COMPRISING THEIR AS ACTIVE COMPONENT | 2002 |
|
RU2315746C2 |
